From: A prospective study examining cachexia predictors in patients with incurable cancer
Univariable analysis | |||
---|---|---|---|
HR | 95% CI | p | |
Age at inclusion | 1.01 | 1.00–1.03 | 0.06 |
Gender | |||
Male | 1.5 | 1.1–2.0 | 0.01 |
Female | 1 | ||
Weight loss (6 months) | 1.6 | 1.4–1.7 | < 0.001 |
BMI | 0.99 | 0.95–1.03 | 0.53 |
Karnofsky PS (0–100) | 0.98 | 0.97–1.00 | < 0.01 |
Fatigue (0–100) | 1.00 | 1.00–1.01 | 0.26 |
Physical functioning (0–100) | 0.99 | 0.99–1.00 | 0.09 |
Emotional functioning (0–100) | 1.00 | 0.99–1.01 | 0.67 |
Food intake | |||
Less than usual | 1.7 | 1.2–2.4 | < 0.01 |
More than usual | 1.0 | 0.6–1.7 | 0.93 |
Unchanged | 1 | ||
Appetite loss (0–100) | 1.01 | 1.01–1.02 | < 0.001 |
Cancer stage | |||
Metastatic/disseminated | 1.7 | 1.0–2.9 | 0.07 |
Local | 1 | ||
Cancer typea | |||
High risk cancer | 4.4 | 2.4–8.1 | < 0.001 |
Neutral risk cancer | 2.1 | 1.4–3.1 | < 0.001 |
Low risk cancer | 1 | ||
Heart disease | 0.9 | 0.6–1.3 | 0.55 |
Renal disease | 1.4 | 0.6–3.1 | 0.45 |
Arthritis | 1.4 | 0.8–2.3 | 0.22 |
COPD | 1.7 | 1.1–2.7 | 0.02 |